The gene TFAP2B, for which the genetic variation was implicated with adipocytokine regulation and type 2 diabetes mellitus [45, 46], had been suggested to play a potential oncogenic role by regulating cancer cell growth and was previously identified as a promising therapeutic target for lung cancer [47]. The gene discussed is TFAP2B; the disease is lung carcinoma.